Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2024-1

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
FNCL
PRCD
HAXNP 2024-1 (USD 60m)Taizhou Huaxin Pharmaceutical Investment Co LtdAPAC
Jan 11, 2024
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
MMI22.0001Oct-23Ejcecl---NsyjbNFJ5.80% b--5.55%-489.00000
Tranche Comments
3 cs: Registration: Czb B Cabc; Comments: BXK60l 3hm UehX. Zrrey Xykemykkzrykn Xecemzkzer/Rek Fzk/HJCX/XHCHX/XylerkmzknRQ/HXZXH/QCHX/HJC Xykn/HQHCHkb/Xyzkzkn Hkbzkkn/HJCHHkb/See Rz Xykemykkzrykn Xecemzkzer (Rryh Qryh)/SZ Xec/HXXX/Rekkkz/Xzhlk. XXS Gnl 5.8% kmek, yzykn Gnl 5.55%. KJXv 30030085BCK266ZB8J23;
Guarantor(s)
Agqzzog Cggaqb Hzgxrgcfgyqcgm Zbpflyrfby Bo Cyk
Use of Proceeds
Vqzbexeebep

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan